| SYS | | 0029157 |
|---|
| LBL | | 00000naa^^22^^^^^^^^450 |
|---|
| 005 | | 20150424143936.0 |
|---|
| 100 | | $a 20090616a2009 m y0sloy0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a TNF-alfa-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer $f M. M. Stankovic ... [et al.] |
|---|
| 215 | | $c ilustr., tab. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 320 | | $a Res. angl. |
|---|
| 463 | -1 | $1 001 sllk_un_cat*0028544 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 56, no. 4 (2009), s. 348-352 $1 210 $a Bratislava $c AEPress $d 2009 $1 215 $a s. 279-370 |
|---|
| 541 | 1- | $a Polymorfizmus promótora TNF-alfa-308 u pacientov s chronickou obštrukčnou chorobou pľúc a rakovinou pľúc $z slo |
|---|
| 606 | 1- | $3 sllk_un_auth*d008173 $a choroby pľúc, obštrukčné $x genetika $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d008175 $a nádory pľúc $x genetika $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d014409 $a faktor nekrotizujúci nádory, alfa $x genetika $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d011110 $a polymorfizmus genetický $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d005838 $a genotyp $2 mesh |
|---|
| 701 | -1 | $3 sllk_un_auth*0010339 $a Stankovic $b M. M. $p Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010340 $a Nestorovic $b A. R. $p Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010341 $a Tomovic $b A. M. $p Modeling and Simulation, Novartis Pharma AG, Basel, Schwitzerland $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010345 $a Petrovic-Stanojevic $b N. D. $p Zvezdara University Medical Center, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010346 $a Andjelic-Jelic $b M. S. $p Zvezdara University Medical Center, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010347 $a Dopudja-Pantic $b V. B. $p Zvezdara University Medical Center, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010348 $a Nagorni-Obradovic $b Lj. M. $p Institute for Tuberculosis and Lung Disease, University Clinical Center of Serbia, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010349 $a Mitic-Milikic $b M. M. $p Institute for Tuberculosis and Lung Disease, University Clinical Center of Serbia, Belgrade, Serbia $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0010350 $a Radojkovic $b D. P. $p Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia $4 070 |
|---|
| 801 | -0 | $a SK $b BA006 $c 20090616 $g AACR2 |
|---|
